Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)

Market Cap	594.32M -28.3%
Revenue (ttm)	314.78M -6.3%
Net Income	27.86M +399.6%
EPS	1.71 +402.9%
Shares Out	n/a
PE Ratio	21.33
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,928
Open	35.99
Previous Close	35.33
Day's Range	35.12 - 36.80
52-Week Range	25.60 - 48.50
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	May 30, 2026

About NSE:BIOFILCHEM

Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and packaging solutions. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Phar...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 26
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BIOFILCHEM

Financial Performance

In fiscal year 2026, NSE:BIOFILCHEM's revenue was 314.78 million, a decrease of -6.27% compared to the previous year's 335.82 million. Earnings were 27.86 million, an increase of 399.55%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 23, 2026

Data Sources Report a data error